FIVE Validation is a Finalist in the CPHI Pharma 2022 Event in Frankfurt.

The CPHI Pharma Awards Ceremony is a celebration of innovative companies within the pharmaceutical sector around the world.

This event recognizes projects that drive significant advances in this field and provides global visibility for groundbreaking ideas.

The 2022 event took place at the Harmonie Hall at Messe Frankfurt in Germany and received more than 181 entries from companies seeking to participate across 10 different categories. 

Among these categories, FIVE Validation stood out as finalist in the "Regulatory Procedures and Compliance" category, thanks to the development of its innovative digital validation software, GO!FIVE®.

FIVE's Validation Lifecycle Management Solution (VLMS) was evaluated by the jury based on four criteria: innovation, process excellence, problem solving and competitive advantage.

After rigorous evaluation, FIVE was ranked as finalist due to the outstanding performance of its validation platform.

CLICK HERE to learn more about GO!FIVE® digital validation software.

"Being selected as one of the four most innovative solutions in Europe in 2022 confirmed that we are on the right track and that clients are increasingly moving towards digital validation. The publication of the second version of the GAMP5 and the CSA guide by the FDA encourages the use of digital tools and agile approaches in validation, making it easier for the Life Sciences market to understand that it is possible to achieve consistent compliance efficiently."

− Silvia Martins, CEO and Co-founder of FIVE Validation.